Avantax Planning Partners’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $515K | Hold |
4,795
| – | – | 0.02% | 263 |
|
|
2025
Q1 | $484K | Buy |
4,795
+33
| +0.7% | +$3.33K | 0.02% | 264 |
|
|
2024
Q4 | $425K | Hold |
4,762
| – | – | 0.02% | 281 |
|
|
2024
Q3 | $399K | Sell |
4,762
-56
| -1% | -$4.69K | 0.01% | 290 |
|
|
2024
Q2 | $371K | Sell |
4,818
-93
| -2% | -$7.16K | 0.01% | 328 |
|
|
2024
Q1 | $336K | Buy |
+4,911
| New | +$336K | 0.01% | 343 |
|
|
2020
Q1 | – | Sell |
-5,344
| Closed | -$242K | – | 273 |
|
|
2019
Q4 | $242K | Sell |
5,344
-177
| -3% | -$8.02K | 0.01% | 263 |
|
|
2019
Q3 | $225K | Buy |
5,521
+80
| +1% | +$3.26K | 0.01% | 279 |
|
|
2019
Q2 | $232K | Buy |
5,441
+38
| +0.7% | +$1.62K | 0.02% | 272 |
|
|
2019
Q1 | $207K | Buy |
5,403
+3,403
| +170% | +$130K | 0.01% | 276 |
|
|
2018
Q4 | $71K | Sell |
2,000
-2,848
| -59% | -$101K | 0.01% | 265 |
|
|
2018
Q3 | $187K | Buy |
+4,848
| New | +$187K | 0.02% | 247 |
|
|
2018
Q2 | – | Sell |
-7,121
| Closed | -$197K | – | 405 |
|
|
2018
Q1 | $197K | Buy |
+7,121
| New | +$197K | 0.02% | 294 |
|
|
2017
Q4 | – | Sell |
-7,044
| Closed | -$205K | – | 313 |
|
|
2017
Q3 | $205K | Buy |
+7,044
| New | +$205K | 0.02% | 353 |
|